Sensex
78,550.60 profit arw 51.43 (0.07%)
Nifty
24,544.75 profit arw -25.90 (-0.11%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 09-Aug-2026
Corporate News
09-Aug-2026     20:22


Novelix Pharmaceuticals to review quarterly results at board meeting on August 13, 2026

Novelix Pharmaceuticals Limited, formerly TRIMURT HI LIMITED, will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, along with a limited review report from the auditors. The company, with Scrip Code 586565 and Scrip Id NOVELIX, has closed the trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the board meeting’s conclusion, in accordance with SEBI regulations.

INDIAN INDICES

Sensex

78,550.60 51.43 (0.07%)

Nifty

24,544.75 -25.90 (-0.11%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,668.04 137.75(0.54%)